First human test: new arthritis Drug's safety check
NCT ID NCT06115967
Summary
This early study tested a new potential rheumatoid arthritis drug called AZD6912 in 40 healthy volunteers. Researchers gave single injections at increasing doses to check for side effects and see how the body processes the drug. The main goal was to determine if the drug is safe enough to test in people with rheumatoid arthritis in future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Montreal, Quebec, H3P 3P1, Canada
-
Research Site
Harrow, HA1 3UJ, United Kingdom
Conditions
Explore the condition pages connected to this study.